About this episode
The episode discusses the need for developers in the longevity space to focus on specific mechanisms rather than abstract concepts of aging.
In this episode, you'll be listening to Sergey Jakimov, managing partner at LongeVC and Artem Trotsyuk, operating partner, US, LongeVC. We discuss how developers in the longevity space should stop chasing aging as an abstract target and concentrate on specific mechanisms that can clearly tackle age-related conditions. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Sergey Jakimov , Managing Partner, LongeVC Artem Trotsyuk , Operating Partner-US, LongeVC
People in this episode
Host: Jennifer C. Smith-Parker
Guests: Sergey Jakimov, Artem Trotsyuk
Topics covered
- longevity investing
- age-related conditions
- mechanisms of aging
- healthcare innovation
- biotechnology
Keywords
- longevity
- aging
- healthcare
- biotech
- investing
- age-related diseases
- LongeVC
Mentioned in this episode
Organizations: LongeVC
More episodes of BioSpace
- Portugal, Spain and the new biotech frontier · June 10, 2026 · 21 min
- Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence · June 10, 2026 · 25 min
- Rethinking hair loss treatment · June 3, 2026 · 22 min
- ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck · June 3, 2026 · 27 min
- France’s biotech ecosystem: science, capital and scale · May 28, 2026 · 21 min
- Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds · May 27, 2026 · 25 min
Explore listener stats, chart rankings, contacts and more on the BioSpace podcast page.